Top Markets
Coin of the day
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
株式のランク #25548
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
株価
$20.01
最終同期: 2025-02-21
時価総額
$48.36M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Singular Genomics Systems, Inc. (OMIC)

カテゴリー

Singular Genomics Systems, Inc.(OMIC)の収益
Sep 2024 時点の収益 TTM: $2.67M
Singular Genomics Systems, Inc. の最新の財務報告によると、現在の収益 (TTM) は $2.67M です。2022 年には $765.00K の収益があり、これは 2021 年の 0.00 と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Singular Genomics Systems, Inc. の収益履歴(2019 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $2.67M -8.42%
2023 $2.91M 280.52%
2022 $765.00K 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
同業他社の収益
企業 収益 収益の差
$11.03B 413,793.47%
US
$34.74B 1,302,846.52%
FR
- -
JP
$20.84B 781,557.91%
US
- -
CH